Intraductal tubulopapillary neoplasm of the pancreas diagnosed by endoscopic ultrasonography-guided fine needle aspirationA 68-year-old man with chronic alcoholrelated pancreatitis and chronic nephropathy requiring dialysis was admitted to the hospital because of a 3-day history of upper abdominal pain. Laboratory tests revealed slightly elevated C-reactive protein with normal amylase and liver function test results. Computed tomography scan of the abdomen showed pancreatic calcifications and a cystic lesion in the head/neck of the pancreas. Subsequent endoscopic ultrasound (EUS) showed a multicystic lesion (▶ Fig. 1) with a dilated main pancreatic duct and a suspected solid lesion (▶ Fig. 2). EUS-guided fine needle aspiration (FNA) of the suspected solid lesion in the main pancreatic duct was performed. Histopathology showed tubulopapillary structures with cylindrical cells and low grade dysplasia (▶ Fig. 3, ▶ Video 1). There were no signs of mucin on periodic acid-Schiff and Alcian blue staining. On immunohistochemistry, the lesion was positive for CK7, CDX2 and MUC-1, and there was focal MUC6 reaction but only very few MUC5AC positive cells. The findings were consistent with an intraductal tubulopapillary neoplasm (ITPN). The patient was considered unfit for surgical treatment, and 6 months following the diagnosis he is alive without signs of disseminated disease. ITPN is relatively rare, accounting for approximately 3 % of all resected pancreatic intraductal neoplasms [1]. It may be radiologically indistinguishable from intraductal papillary mucinous neoplasm (IPMN). The diagnosis is made histologically, as ITPNs exhibit a tubular/cribriform growth with only minimal luminal/ intracellular mucin, whereas IPMNs show a papillary growth pattern [2]. On immunohistochemistry, IPMNs, but not ITPNs, are MUC5AC positive [3]. Although treatment of both tumors is similar, the prognosis of patients with ITPN is typically better than that for IPMN. This might be a relevant consideration when deciding the follow-up of patients, particularly those who are poor surgical candidates. To our knowledge, ours is one of the very few published cases on the appearance of ITPN on EUS and on the utility of EUS-FNA in the differential diagnosis. Endoscopy_UCTN_Code_CCL_1AF_2AZ_3ABCompeting interests None Video 1 Endoscopic ultrasound scan of a pancreatic lesion, ultimately diagnosed following endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) as an intraductal tubulopapillary neoplasm (ITPN).▶ Fig. 1 Endoscopic ultrasound scan of the head and neck of the pancreas showing a multicystic lesion. The patient was a 68-year-old man with chronic alcohol-related pancreatitis and chronic nephropathy. E-Videos E266Kovacevic Bojan et al. Intraductal tubulopapillary neoplasm of the pancreas diagnosed by EUS-FNA … Endoscopy 2017; 49: E266-E267

Aim: endoscopy identifies inflammatory activity, however, it is an unpleasant test and is not always accessible. The aim of the study was to compare the usefulness of quantitative fecal immunochemical test (FIT) versus fecal calprotectin (FC) to determine endoscopic activity in patients with inflammatory bowel disease (IBD).Methods: cross-sectional prospective observational study. The stool samples were collected within three days before starting the preparation for the colonoscopy. We used the Mayo index for ulcerative colitis (UC) and the simplified endoscopic index for Crohn's disease (CD). Mucosal healing (MH) was defined as the score 0 points in each of the endoscopic indices.Results: eighty-four patients were included, 40 (47.6 %) with UC. In patients with IBD, FIT and FC showed a significant correlation with the presence of inflammatory activity/MH on endoscopy, with no statistically significant differences between the two receiver-operating characteristic (ROC) curves. Both tests improved their diagnostic performance when assessing patients with UC; the Spearman correlations between FIT and FC and endoscopic inflammatory activity were r = 0.6 (p = 0.0001) and r = 0.7 (p = 0.0001), respectively. In Crohn's disease, the diagnostic utility of both tests was lower. Conclusions:FIT is an alternative to monitor endoscopic activity among ulcerative colitis patients. In Crohn's disease, more studies are needed to determine the role of fecal biomarkers.

No abstract

No abstract